Patent · US Active

Related substance of linagliptin intermediate and synthesis method thereof

US12122754B2 · kind B2 · utility

0Cited by
0References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 9, 2021
Grant dateOct 22, 2024
Priority date
Expiry dateApr 17, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D239/74
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A related substance of linagliptin intermediate 2-(chloromethyl)-4-methylquinazoline, 4,4′-(2-methylpropane-1,3-diyl)bis(2-(chloromethyl)quinazoline) and a method for synthesizing the related substance (impurity) by reacting 2-(chloromethyl)-4-methylquinazoline with acetaldehyde under an alkaline condition and a purification method are provided. The preparation method is simple and convenient to operate, short in reaction time, high in product purity, and high in yield. The synthesized related substance can be used for qualitative and quantitative analysis of the linagliptin intermediate 2-(chloromethyl)-4-methylquinazoline and API impurities of linagliptin, so that the medication safety of the linagliptin is improved.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.